Company / Interest Expense
Insulet Corporation Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$36.2M
FY2023
5-year range
$36.0M / $61.7M
FY2019-FY2023
Trend
+0.6%
vs FY2022
Sector context
#27 of 40
Health Care
What the data says
At $36M, Insulet Corporation's interest expense ranks #14 of 40 in the Health Care sector. Improved from $62M to $36M over the past 2 years.
Based on SEC 10-K filings.
$36M in FY2023 with a 5-year CAGR of +4.6%.
Improved from $62M to $36M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -9.0%
- 5-Year CAGR
- +4.6%
- 10-Year CAGR
- -
Sector benchmark
#14 of 40 in Health CareTop 32% of 40This company $36.2M Sector average $332.7M
▼
-89.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.6%, indicating consistent growth.
- In FY2023, interest expense increased 0.6% year-over-year.
- Ranks #27 out of 40 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $36.2M | +0.6% |
| FY2022 | $36.0M | -41.7% |
| FY2021 | $61.7M | +28.3% |
| FY2020 | $48.1M | +39.0% |
| FY2019 | $34.6M | +19.7% |
| FY2018 | $28.9M | +36.3% |
| FY2017 | $21.2M | +47.3% |
| FY2016 | $14.4M | +13.2% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026